News
The United States Patent and Trademark Office (USPTO) has introduced new trademark fees for 2025. These changes are designed to address increased operating costs and examination times and they ...
and a registered patent attorney with the United States Patent and Trademark Office (USPTO). James has a background in chemical engineering and has been a pioneer in the budding space of cannabis ...
The application was assigned patent number US 2025/0100558 A1 with the United States Patent and Trademark Office (USPTO) and was published on March 27 th, 2025. The GM patent application was ...
United States Patent and Trademark Office Diagrams within the document indicate that this theoretical EV would package its batteries in a unique way to ensure not only perfect forward and rear ...
The application was assigned patent number US 2025/0091494 A1 with the United States Patent and Trademark Office (USPTO) and was published on March 20 th, 2025. The GM patent application was ...
The company has already suffered a huge setback when the United States Patent and Trademark Office invalidated the vast majority of the patents it was hoping to use against Pocketpair. Losing in ...
today announced that the United States Patent and Trademark Office (USPTO) has issued to Cardiff Oncology U.S. patent No. 12,263,173 with an expected expiration date of no earlier than 2043. The ...
Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO)
today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,274,830. The issued patent gives the Company protection for its method of delivering gaseous ...
This week on IPWatchdog Unleashed, I speak with my long-time friend Jim Carmichael, who is a former Administrative Patent ... of the United States Patent and Trademark Office (USPTO) during ...
April 9, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the ...
Twitter challenged two of the patents in 2017, but the United States Patent Trial and Appeal Board rejected both claims. Jurors found Twitter only willfully infringed upon one part of a patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results